EXPLORE Health Money Travel Food Style Book Club Classifieds #ZoomerDaily Policy & Perspective Arts & Entertainment Stars & ...

Alcon is a global leader in IOLs and controls 40%-50% of the market, by our estimate. Its AcrySof IQ IOL, which was launched in 1994, is most implanted IOL in the world. It was the first IOL to be ...

The forthcoming product launches are a testament to Alcon’s commitment to innovation in the field of eye care. The new phacoemulsification machine and the advanced PanOptix AT-IOL are expected ...

Alcon’s ALC Surgical business continues to gain from its diverse portfolio and incremental innovation. Within Vision Care, the company is registering solid growth, banking on strong sales of its ...

Narrow-moat Alcon reported solid fourth-quarter earnings and ended 2024 on strong footing. Total sales of $2.5 billion were up 7.1% year over year thanks to broad-based growth across the portfolio.

The forthcoming product launches are a testament to Alcon’s commitment to innovation in the field of eye care. The new phacoemulsification machine and the advanced PanOptix AT-IOL are expected to ...

Surgical Business Expands: In terms of the latest developments within Implantables, Alcon’s technology continues to lead the market, with every three IOLs (advanced intraocular lenses ...

CEO David Endicott highlighted 2024 as a strong year for Alcon, with annual sales reaching ... UNITY VCS surgical platform, PanOptix Pro intraocular lens, and the Voyager laser trabeculoplasty ...

TPG-backed ophthalmology specialist BVI Medical will use the investment to fund new product launches and scale its operations ...